These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17061027)

  • 21. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
    Thor KB
    Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
    Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
    Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Duloxetine on Urethral Resting Pressure and on Sphincter Contractility in Response to Coughing and Magnetic Stimulation in Healthy Women.
    Yono M; Otani M; Ito K; Inoue Y; Furukawa K; Hori M; Tsuji S; Tanaka T; Sakata Y; Irie S
    Low Urin Tract Symptoms; 2015 May; 7(2):93-8. PubMed ID: 26663688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The correlation of urethral resistance pressure with maximum urethral closure pressure and stress incontinence.
    Kuhn A; Kuhn P; Dreher E
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):116-20. PubMed ID: 17618730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on duloxetine for the management of stress urinary incontinence.
    Basu M; Duckett JR
    Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine: in stress urinary incontinence.
    McCormack PL; Keating GM
    Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urethral retro-resistance pressure: a new clinical measure of urethral function.
    Slack M; Tracey M; Hunsicker K; Godwin A; Patel B; Sumeray M
    Neurourol Urodyn; 2004; 23(7):656-61. PubMed ID: 15382197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurobiology of stress urinary incontinence: new insights and implications for treatment.
    Cardozo L
    J Obstet Gynaecol; 2005 Aug; 25(6):539-43. PubMed ID: 16234136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Update on medical treatment of female stress urinary incontinence].
    Yazbeck C; Dhainaut C; Batallan A; Thoury A; Madelenat P
    Gynecol Obstet Fertil; 2004 Jun; 32(6):556-61. PubMed ID: 15217571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
    Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
    BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence.
    Fraser MO; Chancellor MB
    BJU Int; 2003 May; 91(8):743-8. PubMed ID: 12709086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
    Lin AT; Sun MJ; Tai HL; Chuang YC; Huang ST; Wang N; Zhao YD; Beyrer J; Wulster-Radcliffe M; Levine L; Chang C; Viktrup L
    BMC Urol; 2008 Jan; 8():2. PubMed ID: 18221532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is location of urethral kinking a confounder of association between urethral closure pressure and stress urinary incontinence?
    Ling C; Shek KL; Gillor M; Caudwell-Hall J; Dietz HP
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):488-492. PubMed ID: 32672377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprostatectomy established stress urinary incontinence treated with duloxetine.
    Collado Serra A; Rubio-Briones J; Puyol Payás M; Iborra Juan I; Ramón-Borja JC; Solsona Narbón E
    Urology; 2011 Aug; 78(2):261-6. PubMed ID: 21601255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with urethral retro-resistance pressure measurement: a prospective pre- and postoperative evaluation in women with stress urinary incontinence.
    Tunn R; Marschke J; Wildt B; Gauruder-Burmester A
    Neurourol Urodyn; 2007; 26(2):262-6. PubMed ID: 17078092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine.
    Vella M; Duckett J; Basu M
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):961-4. PubMed ID: 18231697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.